A bill to require any COVID-19 drug developed in whole or in part with Federal support to be affordable and accessible by prohibiting monopolies and price gouging, and for other purposes.
About This Bill
Committee
Latest Action · August 5, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.